R744

DRUG6 trials

Sponsors

Chugai Pharmaceutical

Conditions

Anemia in Pre-Dialysis PatientsHemodialysis PatientsPeritoneal Dialysis PatientsPredialysis Patients

Phase 3

Correction Study of R744 in Renal Anemia Patients on Hemodialysis

CompletedNCT00433693

Chugai PharmaceuticalHemodialysis Patients

Start: 2007-02-28End: 2008-10-31Updated: 2009-02-02

Clinical Study of R744 to Predialysis Patients

CompletedNCT00433615

Chugai PharmaceuticalAnemia in Pre-Dialysis Patients

Start: 2007-02-28End: 2008-11-30Updated: 2009-02-02

Clinical Study of R744 to Peritoneal Dialysis Patients

CompletedNCT00433849

Chugai PharmaceuticalPeritoneal Dialysis Patients

Start: 2007-02-28End: 2008-11-30Updated: 2009-02-02

Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

CompletedNCT00433888

Chugai PharmaceuticalHemodialysis Patients

Start: 2007-01-31End: 2008-10-31Updated: 2009-02-02

Clinical Study of R744 to Hemodialysis Patients

CompletedNCT00491868

Chugai PharmaceuticalHemodialysis Patients

Start: 2007-06-30End: 2008-08-31Updated: 2009-02-02

Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)

CompletedNCT00492427

Chugai PharmaceuticalPredialysis Patients

Start: 2007-06-30End: 2008-11-30Updated: 2009-01-08